poisar

Stock

Prestige Consumer Healthcare Inc. PBH

$51.92+1.17%

Overview

PBH market data

Price History

PBH price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
14.38
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
11.90
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$3.57
Diluted earnings per share over the trailing twelve months.
Beta
0.33
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
15.6%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$42.62 – $71.07
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
$67.80
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $2.4B · P/B 1.31 · P/S 2.31.

Company News

8 captured
Prestige Consumer Raises FY2027 Adj EPS Guidance from $4.42-$4.51 to $4.55-$4.65 vs $4.53 Est; Raises FY2027 Sales Guidance from $1.100B-$1.121B to $1.290B-$1.315B vs $1.179B EstBenzinga · Aug 6, 2026, 10:04 AM
Prestige Consumer Q1 Adj. EPS $0.98 Beats $0.88 Estimate, Sales $265.700M Beat $249.681M EstimateBenzinga · Aug 6, 2026, 10:00 AM
8-K filing — Prestige Consumer Healthcare Inc. (PBH)SEC EDGAR · Jul 15, 2026, 8:03 PM
Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results DateGlobenewswire Inc · Jul 6, 2026, 12:15 PM
Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, Hagens Berman InvestigatingGlobenewswire Inc · Jun 23, 2026, 8:15 PM
Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $72Benzinga · May 15, 2026, 6:48 PM
Oppenheimer Downgrades Prestige Consumer to PerformBenzinga · May 14, 2026, 5:39 PM
Prestige Consumer Healthcare shares are trading lower after the company reported worse-than-expected Q4 financial results.Benzinga · May 14, 2026, 3:08 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock